Macrogol 3350
Brand names: Movicol, Laxido, Cosmocol
Macrogol 3350 is an osmotic laxative (polyethylene glycol) used to treat chronic constipation and faecal impaction in adults and children.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a high-molecular-weight inert polymer that sequesters water within the gut lumen by osmosis, increasing stool volume and softening consistency to stimulate peristalsis.
Prescribing in practice
- Contraindicated in intestinal obstruction, perforation, ileus and severe inflammatory bowel conditions such as toxic megacolon, where it must be avoided.
- Reconstitute each sachet in water and ensure adequate fluid intake; higher impaction regimens taken over a short period may cause transient abdominal distension.
- Plain macrogol 3350 sachets contain little electrolyte, so they are generally preferred over electrolyte-laden formulations for prolonged maintenance therapy.
Monitoring
Routine monitoring is not required for short-term use, but assess fluid status and response in frail or elderly patients on prolonged or high-dose regimens.
Counselling the patient
- Dissolve the powder fully in water before drinking and keep up your fluid intake.
- It may take a day or two to work; stop and seek advice if you develop severe abdominal pain or vomiting.
Evidence & guidelines
Osmotic macrogol laxatives are recommended by NICE as a first-line option for chronic constipation and for the management of faecal impaction.
Reference: NICE CG99/CKS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021